Literature DB >> 17827440

Anti-oncomir suppression of tumor phenotypes.

Andrei Goga1, Christopher Benz.   

Abstract

MicroRNAs (miRNAs or mirs) are small, non-coding RNAs that bind specific mRNAs and decrease their translation or increase their degradation. miRNAs may modulate the formation and maintenance of tumors by regulating oncogene and tumor suppressor expression. For example, overexpression of a subset of miRNAs has been inversely correlated with certain tumor phenotypes, suggesting a role in tumor suppression. Pairs of oncogenes and the corresponding miRNAs that attenuate their expression have been recently identified. These miRNAs, or "anti-oncomirs," can act as natural inhibitors of oncogene function, indicating the possibility that they might be developed as novel therapeutics.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17827440     DOI: 10.1124/mi.7.4.6

Source DB:  PubMed          Journal:  Mol Interv        ISSN: 1534-0384


  7 in total

1.  MicroRNAs as new players in the genomic galaxy and disease puzzles.

Authors:  Elisa Barbarotto; Paola Secchiero; Abhijit Dasgupta; Paolo Fortina; George A Calin; Terry Hyslop
Journal:  Clin Transl Sci       Date:  2008-05       Impact factor: 4.689

2.  Microvesicle-delivery miR-150 promotes tumorigenesis by up-regulating VEGF, and the neutralization of miR-150 attenuate tumor development.

Authors:  Yuchen Liu; Luming Zhao; Dameng Li; Yuan Yin; Chen-Yu Zhang; Jing Li; Yujing Zhang
Journal:  Protein Cell       Date:  2013-11-07       Impact factor: 14.870

Review 3.  Clinical relevance of KRAS in human cancers.

Authors:  Sylwia Jancík; Jirí Drábek; Danuta Radzioch; Marián Hajdúch
Journal:  J Biomed Biotechnol       Date:  2010-06-07

4.  Decrease of let-7f in low-dose metronomic Paclitaxel chemotherapy contributed to upregulation of thrombospondin-1 in breast cancer.

Authors:  Wei-Yang Tao; Xiao-Shuan Liang; Yang Liu; Chun-Yang Wang; Da Pang
Journal:  Int J Biol Sci       Date:  2015-01-01       Impact factor: 6.580

5.  MicroRNA-214 Promotes Apoptosis in Canine Hemangiosarcoma by Targeting the COP1-p53 Axis.

Authors:  Kazuki Heishima; Takashi Mori; Hiroki Sakai; Nobuhiko Sugito; Mami Murakami; Nami Yamada; Yukihiro Akao; Kohji Maruo
Journal:  PLoS One       Date:  2015-09-03       Impact factor: 3.240

Review 6.  Potential clinical applications of microRNAs as biomarkers for renal cell carcinoma.

Authors:  Yulian Mytsyk; Victor Dosenko; Michał Andrzej Skrzypczyk; Yuriy Borys; Yuriy Diychuk; Askold Kucher; Vasyl Kowalskyy; Serhyi Pasichnyk; Oleh Mytsyk; Lubov Manyuk
Journal:  Cent European J Urol       Date:  2018-07-02

7.  miRNA expression profiling of hereditary breast tumors from BRCA1- and BRCA2-germline mutation carriers in Brazil.

Authors:  Danielle Pessôa-Pereira; Adriane Feijó Evangelista; Rhafaela Lima Causin; René Aloisio da Costa Vieira; Lucas Faria Abrahão-Machado; Iara Viana Vidigal Santana; Vinicius Duval da Silva; Karen Cristina Borba de Souza; Renato José de Oliveira-Silva; Gabriela Carvalho Fernandes; Rui Manuel Reis; Edenir Inêz Palmero; Márcia Maria Chiquitelli Marques
Journal:  BMC Cancer       Date:  2020-02-22       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.